⌘K

Login Start Free

Home/Filings/4/0001209191-23-026757

4//SEC Filing

Watkins Thomas 4

Accession 0001209191-23-026757

CIK 0001492426other

View on SEC.gov Company Profile

Filed

May 1, 8:00 PM ET

Accepted

May 2, 7:32 PM ET

Size

8.7 KB

Accession

0001209191-23-026757

Insider Transaction Report

Form 4

Period: 2023-04-28

Horizon Therapeutics Public Ltd CoHZNP

Director

Transactions

Exercise/Conversion
Ordinary Shares
2023-04-28+3,913→ 29,124 total
Exercise/Conversion
Restricted Stock Units
2023-04-28−3,913→ 0 total
From: 2023-04-28Exp: 2023-04-28→ Ordinary Shares (3,913 underlying)

Holdings

Ordinary Shares
(indirect: By Trust)
55,953
Ordinary Shares
(indirect: By Partnership)
10,000

Footnotes (2)

[F1]Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
[F2]19,211 Ordinary Shares previously reported as indirectly held by Trust held directly.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Horizon Therapeutics Public Ltd Co

CIK 0001492426

Entity typeother

Related Parties

1

filerCIK 0001307935

Filing Metadata

Form type: 4
Filed: May 1, 8:00 PM ET
Accepted: May 2, 7:32 PM ET
Size: 8.7 KB

View on SEC.gov